Abstract
The purpose of this paper is to review current knowledge and provide advice on breastfeeding, formula feeding of term infants (including which type of formula may be appropriate for a given patient), and the timing and composition of complementary feeding. The review is primarily aimed at children living in Europe, generally in an industrialised country. In brief, all infants should be exclusively breastfed from birth to about 6 months (26 weeks) of age or at least for the first 4 months (18 weeks) of life. Breastfeeding should preferably continue beyond the first year of life. Infants who cannot be breastfed, or should not receive breast milk, or for whom breast milk is not available, require breast milk substitutes of high quality. Based on the available evidence, it is reasonable to advise that for all infants, complementary foods should not be given before 17 weeks and should be introduced by 26 weeks; however, no data are available to form evidencebased recommendations. New foods should not be introduced too often – generally not more frequently than every 3 days – nor should more than one new food be introduced at a time.
Keywords: Infant feeding, childhood, infancy, complementary feeding
Current Pediatric Reviews
Title: Nutrition in Infancy
Volume: 3 Issue: 4
Author(s): Hania Szajewska and Andrea Horvath
Affiliation:
Keywords: Infant feeding, childhood, infancy, complementary feeding
Abstract: The purpose of this paper is to review current knowledge and provide advice on breastfeeding, formula feeding of term infants (including which type of formula may be appropriate for a given patient), and the timing and composition of complementary feeding. The review is primarily aimed at children living in Europe, generally in an industrialised country. In brief, all infants should be exclusively breastfed from birth to about 6 months (26 weeks) of age or at least for the first 4 months (18 weeks) of life. Breastfeeding should preferably continue beyond the first year of life. Infants who cannot be breastfed, or should not receive breast milk, or for whom breast milk is not available, require breast milk substitutes of high quality. Based on the available evidence, it is reasonable to advise that for all infants, complementary foods should not be given before 17 weeks and should be introduced by 26 weeks; however, no data are available to form evidencebased recommendations. New foods should not be introduced too often – generally not more frequently than every 3 days – nor should more than one new food be introduced at a time.
Export Options
About this article
Cite this article as:
Szajewska Hania and Horvath Andrea, Nutrition in Infancy, Current Pediatric Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339607782411529
DOI https://dx.doi.org/10.2174/157339607782411529 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aminoglycoside Nephrotoxicity
Current Drug Targets - Infectious Disorders Additive Effect of MCP in Combination with Cefotaxime Against Staphylococcus aureus
Medicinal Chemistry Antibacterial Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles Towards Streptococcus agalactiae
Current Pharmaceutical Biotechnology Special Features of Gram-Positive Bacterial Eradication by Photosensitizers
Recent Patents on Anti-Infective Drug Discovery Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms
Current Topics in Medicinal Chemistry Nanomedical Strategies for Targeting Skin Microbiomes
Current Drug Metabolism Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Current Pharmaceutical Design Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives
Medicinal Chemistry Antimicrobial Peptides and Peptidomimetics - Potent Therapeutic Allies for Staphylococcal Infections
Current Pharmaceutical Design Scintigraphic Imaging of Inflammatory Processes
Medicinal Chemistry Reviews - Online (Discontinued) Prevention of Cardiovascular Complications in the Marfan Syndrome
Vascular Disease Prevention (Discontinued) Acute Decompensated Heart Failure Update
Current Cardiology Reviews Unique Applications of Novel Antifungal Drug Combinations
Anti-Infective Agents in Medicinal Chemistry The Development of Antimicrobial Peptides as New Antibacterial Drugs
Current Protein & Peptide Science Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis
Current Clinical Pharmacology High Sensitivity C-Reactive Protein (hsCRP): A New Biochemical Marker of Atherosclerotic Vascular Disease
Current Cardiology Reviews Para-prosthetic Leaks Following Mitral Valve Replacement: Case Analysis on a 20-year Period
Current Cardiology Reviews Recent Tools to Overcome Antibacterial Resistance
Current Topics in Medicinal Chemistry The Human Microbiome Project, Personalized Medicine and the Birth of Pharmacomicrobiomics
Current Pharmacogenomics and Personalized Medicine The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design